BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Warner Bros
WBD
|
+$2.81B |
| 2 |
Linde
LIN
|
+$2.35B |
| 3 |
Chevron
CVX
|
+$1.53B |
| 4 |
Pfizer
PFE
|
+$1.38B |
| 5 |
UnitedHealth
UNH
|
+$1.35B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$3.75B |
| 2 |
CERN
Cerner Corp
CERN
|
+$2.23B |
| 3 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$1.1B |
| 4 |
Baidu
BIDU
|
+$1.07B |
| 5 |
NXP Semiconductors
NXPI
|
+$998M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.27% |
| 2 | Healthcare | 15.23% |
| 3 | Financials | 12.33% |
| 4 | Consumer Discretionary | 9.59% |
| 5 | Industrials | 8.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SJR
3276
DELISTED
Shaw Communications Inc.
SJR
| $13.7M | ﹤0.01% |
464,472
-27,316
| -6% | -$791K |
|
3277
EverQuote
EVER
$832M
| $13.7M | ﹤0.01% |
1,546,356
-84,910
| -5% | -$970K |
|
3278
Amylyx Pharmaceuticals
AMLX
$2.65B
| $13.7M | ﹤0.01% |
709,432
+137,091
| +24% | +$1.63M |
|
3279
BayCom
BCML
$335M
| $13.7M | ﹤0.01% |
660,708
+587,498
| +802% | +$12.9M |
|
3280
Bioventus
BVS
$943M
| $13.6M | ﹤0.01% |
1,999,849
+216,762
| +12% | +$2.21M |
|
3281
Hovnanian Enterprises
HOV
$788M
| $13.6M | ﹤0.01% |
318,153
-32,189
| -9% | -$1.56M |
|
|
QUOT
3282
DELISTED
Quotient Technology Inc
QUOT
| $13.6M | ﹤0.01% |
4,583,090
-766,865
| -14% | -$3.64M |
|
3283
Tilly's
TLYS
$126M
| $13.6M | ﹤0.01% |
1,938,076
-113,546
| -6% | -$948K |
|
3284
iShares Core Conservative Allocation ETF
AOK
$794M
| $13.6M | ﹤0.01% |
392,717
-1,126
| -0.3% | -$40.1K |
|
3285
Veritone
VERI
$114M
| $13.5M | ﹤0.01% |
2,071,468
+173,570
| +9% | +$1.75M |
|
|
VWE
3286
DELISTED
Vintage Wine Estates, Inc. Common Stock
VWE
| $13.5M | ﹤0.01% |
1,715,611
+1,570,872
| +1,085% | +$14.5M |
|
|
FINV
3287
FinVolution Group
FINV
$1.14B
| $13.5M | ﹤0.01% |
2,837,151
+225,806
| +9% | +$911K |
|
3288
NextDecade
NEXT
$1.79B
| $13.5M | ﹤0.01% |
3,035,389
+1,260,198
| +71% | +$7.82M |
|
3289
eGain
EGAN
$201M
| $13.5M | ﹤0.01% |
1,380,422
+17,235
| +1% | +$172K |
|
|
SCU
3290
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $13.5M | ﹤0.01% |
1,611,834
+148,213
| +10% | +$1.63M |
|
3291
ALX Oncology
ALXO
$266M
| $13.4M | ﹤0.01% |
1,662,282
+306,804
| +23% | +$3.34M |
|
3292
Century Casinos
CNTY
$33.5M
| $13.4M | ﹤0.01% |
1,866,537
-34,598
| -2% | -$323K |
|
3293
Nomura Holdings
NMR
$29.1B
| $13.4M | ﹤0.01% |
3,753,964
-597,665
| -14% | -$2.28M |
|
3294
Liquidia Corp
LQDA
$7.92B
| $13.3M | ﹤0.01% |
3,059,171
+2,212,786
| +261% | +$11.4M |
|
3295
Phathom Pharmaceuticals
PHAT
$676M
| $13.3M | ﹤0.01% |
1,577,737
+199,220
| +14% | +$2.05M |
|
3296
RxSight
RXST
$247M
| $13.3M | ﹤0.01% |
942,540
+206,951
| +28% | +$2.73M |
|
|
PFHD
3297
DELISTED
Professional Holding Corp. Class A Common stock
PFHD
| $13.3M | ﹤0.01% |
661,205
+594,537
| +892% | +$13.1M |
|
3298
PCB Bancorp
PCB
$392M
| $13.2M | ﹤0.01% |
707,153
+551,255
| +354% | +$11.2M |
|
|
OMIC
3299
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $13.1M | ﹤0.01% |
114,535
+20,179
| +21% | +$2.37M |
|
|
USBF
3300
DELISTED
iShares Trust iShares USD Systematic Bond ETF
USBF
| $13.1M | ﹤0.01% |
150,000
| – | – |
|
Similar funds
BlackRock's Q2 2022 Portfolio in Review
As of Q2 2022, BlackRock held 6,138 positions worth $3.12T, down 16% from $3.71T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q2 2022 filing shows 278 new, 2,738 increased, 2,354 reduced and 221 closed positions. Its largest new stake was Aspen Technology Inc: 2,824,931 shares worth $519M. The largest sale was AT&T, an estimated $3.75B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2022 buy was Aspen Technology Inc: 2,824,931 shares worth $519M.
- BlackRock added most to Warner Bros in Q2 2022, an estimated $2.81B increase.
- BlackRock's biggest Q2 2022 reduction was AT&T, cutting an estimated $3.75B.
- BlackRock fully exited Cerner Corp in Q2 2022, selling an estimated $2.23B.
- BlackRock's ten largest holdings make up 19% of its $3.12T portfolio in Q2 2022.
- BlackRock opened 278 new positions and closed 221 in Q2 2022.
- BlackRock's portfolio value fell 16% quarter-over-quarter to $3.12T.
Based on BlackRock's 13F filing for Q2 2022, filed 12 Aug 2022.